Skip to main content
Premium Trial:

Request an Annual Quote

Green Super Rice Project Selects Affymetrix for Genotyping Activities

NEW YORK (GenomeWeb) – Affymetrix today announced it will be the genotyping supplier for a project to develop 15 new rice varieties for small-scale farmers in Africa and Asia.

The Green Super Rice (GSR) project has selected the Santa Clara, California-based firm to supply genotyping microarrays for its molecular breeding activities. Affymetrix screened 2 million SNPs from the 3000 Rice Genomes Project to design an array specifically for the project, the Axiom GSR Rice Array. The new array will feature approximately 55,000 markers and will enable ultra-high-throughput processing and analysis of 384 samples at a time, the firm said in a statement.

"We selected the Axiom genotyping platform from Affymetrix due to the platform's capability to screen millions of markers and accurately transfer them to smaller 384HT format arrays," GSR project director Zhikang Li said in a statement. "Such precision and fidelity is not available on any other genotyping platform."

The GSR project is aiming to develop 15 new rice varieties in the next three years to help boost rice productivity. It is funded by the Bill & Melinda Gates Foundation and the Chinese government and is coordinated by the Chinese Academy of Agricultural Sciences.

In July, Affymetrix announced a partnership with RUCDR Infinite Biologics to genotype samples from the National Institute of Drug Abuse using a custom array it designed with BioRealm.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more